Free Trial

Hinge Health (NYSE:HNGE) Now Covered by Royal Bank of Canada

Hinge Health logo with Services background

Equities research analysts at Royal Bank of Canada assumed coverage on shares of Hinge Health (NYSE:HNGE - Get Free Report) in a research note issued on Monday,Briefing.com Automated Import reports. The firm set an "outperform" rating and a $45.00 price target on the stock. Royal Bank of Canada's price target would suggest a potential upside of 29.46% from the stock's current price.

Other equities analysts have also issued research reports about the stock. Bank of America assumed coverage on shares of Hinge Health in a report on Monday. They set a "buy" rating and a $42.00 price objective on the stock. Morgan Stanley began coverage on Hinge Health in a research note on Monday. They set an "overweight" rating and a $46.00 price target on the stock. KeyCorp began coverage on Hinge Health in a research note on Monday. They issued an "overweight" rating and a $45.00 price objective for the company. Evercore ISI initiated coverage on Hinge Health in a research report on Monday. They set an "outperform" rating and a $50.00 target price on the stock. Finally, Raymond James assumed coverage on shares of Hinge Health in a research report on Monday. They issued an "outperform" rating and a $45.00 price target for the company. One investment analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $46.00.

Read Our Latest Stock Report on HNGE

Hinge Health Stock Down 0.7%

Hinge Health stock opened at $34.76 on Monday. Hinge Health has a 12-month low of $33.42 and a 12-month high of $43.80.

Hinge Health Company Profile

(Get Free Report)

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Hinge Health Right Now?

Before you consider Hinge Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hinge Health wasn't on the list.

While Hinge Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now
Palantir at All-Time Highs: Take Profits or Hold the Line?
3 Tech Stocks Insiders Are Buying: Speculative Plays for June

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines